Skip to main content

Table 1 Overview of patient characteristics and rare/novel sequence variants identified by next-generation sequencing

From: Protein modeling to assess the pathogenicity of rare variants of SERPINA1 in patients suspected of having Alpha 1 Antitrypsin Deficiency

Patient ID

AAT serum level (mg/dL)

CRP (mg/dL)

Previous phenotypes

Age (yrs)

Sex

NGS DNA analysis

Novel mutant nucleotide changes

Consequence

Genotype

Splice variants

 2250

70

5.9

–

65

F

Novel splice variant: G > C at position +1 of intron 1C

 

E376D – M3 allele

 24023

62.8

–

 

71

M

917 + 1G > A

Affects the normal mRNA splicing.

E376D – M3 allele

Deletions

 10724

52

7.3

M3

49

M

A347fs: Novel 1 bp deletion (1112delC) at position 347

Frameshift that extends the protein by 5 amino acids

E376D – M3 allele

Stop codons

 6326e

2

0

Z/M1

57

F

Q156X: C > T at Chr14:94849037 (GRCh.37.p13) c.538C > T

Insertion of stop codon at position 156

Q156X E342K – Z allele V213A – M1 allele

 6376e

98

7

I

54

M

Q156X: C > T at Chr14:94849037 (GRCh.37.p13) c.538C > T

Insertion of stop codon at position 156

Q156X R39C – I allele

 19771

91.4

–

M

57

 

G192Fs: 1 bp deletion at Chr14:94847477 (GRCh37.p13) c.647_647delG

Predicted to produce a premature stop codon at amino acid 214, leading to a premature termination on exon III

 

Single-nucleotide variations

 CA97

112

–

M3 M2/4

65

F

GAG > AAG

 

E204K – rarea E376D – M3 allele

R101H – M2/M4 allele

 1144

72

–

M1

61

M

CCC > TCC

 

P289S – rarea V213A – M1 allele

 2343

86

3.6

M1

60

F

ATC > AAC

 

I9N [includes precursor] – rarea V213A – M1 allele

 4293d

66

0.5

M1

54

M

CCC > CTC

Q0Bellingham – insertion of stop codon at position 156

P28L – rarea K217X – Q0Bellingham V213A – M1 allele

 5564d

67

1.6

M1

51

F

CCC > CTC

Q0Bellingham – insertion of stop codon at position 156

P28L – rarea K217X – Q0Bellingham V213A – M1 allele

 4668

78

2.2

M3

62

M

ATC > AAC

 

I50N (PiTijarafe) – rare E376D – M3 allele

 9533

73

0.9

–

60

M

ATG > ACG

 

M385 T – rarec M allele

 10889

–

12.5

M3

34

F

CAG > CGG

 

Q40R – rarea E376D – M3 allele

 12642

89

0.6

M3

66

F

GAC > CTC

 

D341V – rareb E376D – M3 allele P = L118 – no amino acid change

 14271

47

0.6

Z/M1

61

F

ATG > ACG

 

M221 T – rarea V213A – M1 allele E342K – Z allele

 15230

34

1

Z/M1

72

M

GTG > GAG

 

V210E (Ncambodia/Pierre-bénite) – rarea V213A – M1 allele E342K – Z allele

 17,657

160

1.5

M3/M4

87

M

AAG > GAG

 

K174E – NOVELa E376D – M3 allele R101H – M2/M4 allele

 21034

121.2

–

–

47

F

CCC > CAC

 

P369H – rare

E264V – S allele

 21636

88.4

–

–

58

M

GTG > ATG

 

V333 M – rarec E376D – M3 allele R101H – M4 allele

 23523

118.6

–

–

48

F

GCA > CCA

 

A325P (Nvestenanova) – rarea R223C – F allele E376D – M3 allele R101H – M4 allele

 24319

79.3

–

–

57

F

GCC > GAC

 

A142D – rarec

E264V – S allele V213A – M1 allele

 76430

74.8

–

–

59

M

CAC > TAC

 

H262Y – rarec M allele

  1. All SNVs are reported without the 24 amino acid precursor unless otherwise stated
  2. aSNVs have been previously reported in dbSNP (E204K – rs199422208; P289S – rs779938258; Q40R – rs763483402; M221 T – rs766260108; K174E – rs766034720; I9N [includes precursor] – rs1296175763; P28L – rs944607375)
  3. bSNVs have been previously reported in dbSNP and linked to AATD (D314V – rs864622046)
  4. cSNV previously reported in the literature (20–26) (H262Y – rs149537225; V333 M – 373,630,097; A142D – rs142942004; V210E – rs746197812; M385 T – rs1488213352; A325P – rs376024688; I50N – rs1275309068)
  5. dFamilial samples from brother (4293) and sister (5564)
  6. eFamilial samples from brother (6376) and sister (6326)
  7. bp Base pair, dbSNP Database of single nucleotide polymorphisms, SNV Single nucleotide variation